SBI Mutual Fund invests in Lenskart pre-IPO with a Rs 100 crore stake purchase at Rs 402 per share. The deal comes as promoter Neha Bansal trims her stake ahead of the October 31, 2025 IPO. Full details on funding, valuation, expansion and investor sentiment.
Author: KUBERGROW TEAM
boAt Parent SEBI Approval: Big ₹1,500 Crore IPO Move Explained (2025)
boAt Parent SEBI Approval secured for a ₹1,500 crore IPO. Here’s what investors need to know about issue breakup, financials, and valuation outlook.
OYO Unlisted Share Value Soars: Sunday Hotels Expansion Adds Growth Momentum
OYO Unlisted Share Value may gain momentum as the company expands its premium Sunday Hotels brand across India’s top wildlife destinations. Follow KuberGrow for insights.
Lenskart Q1 FY26 Profit rises to Rs 61 crore as revenue grows 25% ahead of IPO
Lenskart Q1 FY26 profit rises to Rs 61 crore with revenue growth of 25% year-on-year, driven by strong sales and cost efficiency. The eyewear brand prepares for its ₹2,150 crore IPO amid growing investor confidence.
Studds Accessories IPO 2025: Everything Investors Must Know Before Subscription
Studds Accessories IPO opens on Oct 30 with ₹557-585 price band. Learn subscription details, freeze update, valuation outlook & investor guidance.
Groww IPO Update: ISIN Freeze Initiated for Groww
Groww has initiated an ISIN freeze ahead of its IPO. Learn how this impacts shareholders, trading restrictions, and key details about the Groww IPO 2025.
Shadowfax, PNGS, Rayzon Solar, Asset Reconstruction Company and 3 more IPOs get SEBI approval
Shadowfax PNGS Rayzon Solar Asset Reconstruction Company IPOs SEBI approval: Seven companies get SEBI green signal for upcoming IPOs. Get details on funding, offer-for-sale, and listing timeline exclusively on KuberGrow News.
Orkla India IPO 2025: MTR and Eastern Spices Parent Launches ₹10,000 Cr Public Issue on Oct 29
Orkla India IPO 2025 opens on October 29 via pure offer-for-sale of 2.28 crore shares. Get details on price band, financials, and listing dates — exclusively on KuberGrow News.
PharmEasy-Owned Thyrocare Q2 Profit Soars 81% YoY To INR 48 Crore
PharmEasy-Owned Thyrocare Q2 Profit rises 81% YoY to INR 48 crore in Q2 FY26, driven by strong pathology growth, margin gains, and record test volumes. Learn how KuberGrow tracks such market leaders in the unlisted and listed space.
Arohan Financial Services Apprenticeship Recognised for Excellence in Skill Development
Arohan Financial Services Apprenticeship receives national recognition for excellence, empowering youth and promoting skill development across India.
